Liver transplantation. Living donor, hepatocyte, and xenotransplantation.
Liver transplantation is now accepted as effective therapy in the treatment of acute and chronic hepatic failure. Improvements in surgical techniques and immune suppression have led to 5-year survival rates that exceed 70% in most centers. The success of transplantation has led to a dramatic increase in the number of candidates to over 14,000 places on the national waiting list. While the number of patients in need of transplantation increases, there has been little growth in the supply of available cadaveric organs, resulting in an organ shortage crisis. With waiting times often exceeding 1 to 2 years, the waiting list mortality now exceeds 10% in most regions. Several novel approaches have been developed to address the growing disparity between the limited supply and excessive demand for suitable organs.
Sterling
R K
RK
Section of Hepatology, Division of Transplantation, Medical College of Virginia at Virginia Commonwealth University, Richmond, Virginia, USA. rksterli@hsc.vcu.edu
Fisher
R A
RA
D000328:Adult; D000818:Animals; D017690:Cell Transplantation / Q000379:methods; D002648:Child; D006084:Graft Rejection; D006085:Graft Survival; D006498:Hepatectomy / Q000379:methods* / Q000706:statistics & numerical data; D006801:Humans; D008107:Liver Diseases / Q000601:surgery; D016031:Liver Transplantation / Q000379:methods* / Q000523:psychology / Q000706:statistics & numerical data; D019520:Living Donors / Q000706:statistics & numerical data; D012307:Risk Factors; D013997:Time Factors; D020858:Tissue and Organ Harvesting / Q000379:methods; D014183:Transplantation, Heterologous / Q000379:methods; D014850:Waiting Lists